A director at Varex Imaging Corp sold 4,007 shares at 12.810USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Credit markets are overstating VREX's credit risk with a YTW of 7.269%, relative to an Intrinsic YTW of 5.959% and an Intrinsic CDS of 302bps. Meanwhile, Moody's is also materially overstating the firm's fundamental credit risk, with its highly speculative B2 credit rating seven notches lower than Valens' IG4+ (Baa1) credit rating. Incentives Dictate Behavior™ analysis highlights mixed signals for VREX credit holders. Management's compensation metrics should drive management to improve margins ...
Credit markets are overstating VREX's credit risk with a YTW of 5.827%, relative to an Intrinsic YTW of 4.677% and an Intrinsic CDS of 284bps. Meanwhile, Moody's is materially overstating the firm's fundamental credit risk, with its highly speculative B2 credit rating seven notches lower than Valens' IG4+ (Baa1) credit rating. Incentives Dictate Behavior™ analysis highlights mostly positive signals for VREX credit holders. Management's compensation framework should drive them to focus on all th...
Credit markets are overstating VREX's credit risk with a YTW of 5.236%, relative to an Intrinsic YTW of 3.986% and an Intrinsic CDS of 280bps. Meanwhile, Moody's is also materially overstating the firm's fundamental credit risk, with its highly speculative B2 credit rating seven notches lower than Valens' IG4+ (Baa1) credit rating. Incentives Dictate Behavior™ analysis highlights mostly positive signals for VREX credit holders. Management's compensation framework should drive them to focus on a...
Hillenbrand (HI) has pivoted successfully to roll-up the industrial machinery industry in the past decade, giving the business greater growth potential and opportunities for asset efficiency. Uniform Accounting highlights these efficiency improvements that the market is missing, indicating equity upside. Over the last decade, Hillenbrand has expanded its business from a casket business into the industrial machinery industry, causing Uniform ROA to improve to stable 25%-28% levels. It has acqu...
Varex Imaging Corporation (VREX:USA) currently trades below corporate averages relative to UAFRS-based (Uniform) earnings, with a 14.9x Uniform P/E. At these levels, the market is pricing in bullish expectations for the firm, but management may have concerns about industrial and medical demand, gross margins, and supply chain issues. Specifically, management may lack confidence in their ability to sustain improvements in gross margin and manufacturing productivity, maintain their cash balance, ...
Credit markets are materially overstating VREX's credit risk with a YTW of 4.920%, relative to an Intrinsic YTW of 3.140% and an Intrinsic CDS of 235bps. Meanwhile, Moody's is also materially overstating the firm's fundamental credit risk, with its highly speculative B2 credit rating seven notches lower than Valens' IG4+ (Baa1) credit rating Incentives Dictate Behavior™ analysis highlights mostly positive signals for VREX credit holders. Management's compensation framework should drive them to ...
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Current market expectations for CommScope Holding Company (COMM) do not understand the company's macro tailwinds. The company supplies the technology that allows big macro trends around 5G and WiFi expansion and the Internet of Things explosion they are fueling. Its tailwinds from being an essential supplier to these markets taking off position COMM for significant upside. As booming demand accelerates in these end markets, the company's likely to see strong fundamental momentum the market is...
Varex Imaging Corporation (VREX:USA) currently trades below corporate averages relative to UAFRS-based (Uniform) earnings, with an 18.4x Uniform P/E. Even at these levels, the market is pricing in bullish expectations for the firm, but management may have concerns about operating margins, R&D spending, and their nanotube technology potential. Specifically, management may lack confidence in their ability to sustain non-GAAP operating margin improvements, improve fluoroscopy and dental revenues, ...
Credit markets are materially overstating VREX's credit risk with a YTW of 4.838%, relative to an Intrinsic YTW of 3.248% and an Intrinsic CDS of 242bps. Meanwhile, Moody's is also materially overstating the firm's fundamental credit risk, with its highly speculative B2 credit rating seven notches lower than Valens' IG4+ (Baa1) credit rating Incentives Dictate Behavior™ analysis highlights mostly positive signals for VREX equity holders. Management's compensation framework should drive them to ...
Credit markets are grossly overstating VREX's credit risk with a YTW of 6.284%, relative to an Intrinsic YTW of 3.454% and an Intrinsic CDS of 299bps. Meanwhile, Moody's is materially overstating the firm's fundamental credit risk, with its highly speculative B2 credit rating seven notches lower than Valens' IG4+ (Baa1) credit rating Incentives Dictate Behavior™ analysis highlights mostly positive signals for VREX credit holders. Management's compensation framework should drive them to focus on...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Key Points: Many health care names are staging reversals and breaking above bullish bases, including IVC, CUTR, VREX, EHC, SEM, AMED, MD, HAE, RGEN, BIO, LCI, PBH, Semiconductor and semi-suppliers continue to be leadership (ex. ACLS, VECO, COHU, QRVO, SWKS, SYNA, CRUS, SMTC, QCOM) A number of auto component suppliers appear to be bottoming (ex. AXL, DAN, BWA)
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.